'S­tuck in the past': Athi­ra hits back at bil­lion­aire backer and his bid to put oust­ed CEO Leen Kawas back in the pic­ture

The fight over con­trol over the fu­ture of Alzheimer’s biotech Athi­ra Phar­ma is on.

Days af­ter bil­lion­aire backer Richard Kayne launched an at­tack on the cur­rent lead­er­ship team at Athi­ra and pro­posed in­sert­ing him­self on the board of di­rec­tors along­side ex-No­var­tis CFO George Bick­er­staff, Athi­ra’s board re­spond­ed with a let­ter to share­hold­ers plead­ing for their sup­port in vot­ing for three di­rec­tors of its choice in­stead: Joe Edel­man, John Fluke and Grant Pick­er­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER